Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

15 High Dividend Stocks with the Highest Yields in their Sectors

Defensive investors like investing in high dividend stocks as such stocks can protect them from inflationary risks. We are concerned about the Fed’s inflationary monetary policy and therefore we recommend investors to play defensively by purchasing stocks with high dividend yields.

Below we compiled a list of high dividend stocks with the highest dividend yields in their sectors. All companies have at least $10 billion market cap and over 4% dividend yield, and are among the top two in their sectors in terms of dividend yields. The market data is sourced from Finviz.

ETON PARK CAPITAL

Here are the eight stocks with the highest yields in their sectors.

YPF S.A. (YPF): YPF SA is an Argentinean integrated oil and gas company. YPF has a dividend yield of 9.45% and lost 25.72% since the beginning of this year. It has a market cap of $14.1B and a P/E ratio of 11.03. Eric Mindich had $440 million of YPF shares. Rob Citrone, Philippe Jabre, and Jeffery Altman also all invested about $50 million in YPF.

Altria Group Inc. (MO): Altria Group is the biggest cigarettes manufacturer in the world. MO has a dividend yield of 5.93% and returned 17.46% since the beginning of this year. It has a market cap of $56.9B and a P/E ratio of 16.56. Tom Russo had $187 million invested in MO shares.

Annaly Capital Management, Inc. (NLY): Annaly Capital Management owns, manages and finances a portfolio of real estate related investments. NLY has a dividend yield of 14.51% and returned 2.61% since the beginning of this year. It has a market cap of $16.0B and a P/E ratio of 8.61. Bill Miller invested $66 million in NLY shares.

AstraZeneca PLC (AZN): AstraZeneca is a global biopharmaceutical company. AZN has a dividend yield of 5.78% and returned 6.96% since the beginning of this year. It has a market cap of $61.5B and a P/E ratio of 6.4. Renaissance Technologies and David Dreman both had over $20 million of AZN.

Lockheed Martin Corporation (LMT): Lockheed Martin Corporation is a security company engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems and products. LMT has a dividend yield of 5.10% and gained 15.47% since the beginning of this year. It has a market cap of $25.4B and a P/E ratio of 9.84. Jean-Marie Eveillard had $278 million LMT stocks.

Paychex Inc. (PAYX): Paychex provides payroll, human resource, and benefits outsourcing solutions for small to medium-sized businesses. PAYX has a dividend yield of 4.33% and lost 0.37% since the beginning of this year. It has a market cap of $10.7B and a P/E ratio of 20.12. David Blood, Miguel Nogales, and Al Gore had $90 million invested in PAYX.

France Telecom (FTE): France Telecom SA is a France-based telecommunications operator. FTE has a dividend yield of 10.97% and lost 7.34% since the beginning of this year. It has a market cap of $46.8B and a P/E ratio of 11.12. Steven Cohen had $223,000 invested in FTE.

Cia Energetica de Minas Gerais (CIG): CIG is a Brazil-based holding company mainly engaged in the generation, transmission and distribution of electricity. CIG has a dividend yield of 6.51% and returned 9.55% since the beginning of this year. It has a market cap of $11.7B.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!